Nanoparticles That Clear Scar-Driving Immune Cells Open Tumors to Immunotherapy
Memorial Sloan Kettering scientists engineered fucoidan-coated nanoparticles that selectively eliminate senescent, P-selectin-positive macrophages driving fibrosis, dissolving scar barriers around tumors ...
